192P Use of biosimulation to predict homologous recombination deficiency and PARPi benefit in patients with ovarian, pancreatic, prostate and triple negative breast cancers
2024 · Annals of Oncology · 0 citations
https://doi.org/10.1016/j.annonc.2024.08.2197